Sort
64,565 grants matching “drug discovery”
SBIR Phase II: ElectroNanospray Process for Nanoformulating Drugs
$570,098Robert A Hoerr · Nanocopoeia Inc. · · FY2008 · TIP
High-Throughput, Highly Multiplexed In Situ Proteomic Imaging of Human Tissues
$570,000Peng Yin · Harvard University · UH3 · FY2020 · CA
Discovery and Analysis of Synthetic TLR Agonists and Antagonists
$570,000Bruce A Beutler · Scripps Research Institute, The · U24 · FY2009 · AI
Core 4: Animal Breeding (UAB) and Exposure Core (MRIGLOBAL)
$569,977Mohammad Athar · University Of Alabama At Birmingham · U54 · FY2020 · ES
Administrative Core
$569,956Rick Hoyle · Duke University · P30 · FY2014 · DA
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
$569,944Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
UCSD Cancer Center Training Program in Drug Development
$569,911Michael Bouvet · University Of California, San Diego · T32 · FY2018 · CA
Metabolomics of cGVHD
$569,841Bruce R. Blazar · Dana-Farber Cancer Inst · P01 · FY2023 · HL
COMMUNITY BASED RESEARCH ON DRUG USE NETWORKS
$569,835Affiliated Systems Corporation · R01 · FY2004 · DA
Paul Calabresi Clinical Oncology Award
$569,799Scott Kopetz · University Of Tx Md Anderson Can Ctr · K12 · FY2024 · CA
Integrative Approach to Divergent Remodeling in Thin Filament Cardiomyopathies
$569,776Jil C Tardiff · University Of Arizona · R01 · FY2022 · HL
Integrative Approach to Divergent Remodeling in Thin Filament Cardiomyopathies
$569,776Jil C Tardiff · University Of Arizona · R01 · FY2023 · HL
Integrative Approach to Divergent Remodeling in Thin Filament Cardiomyopathies
$569,776Jil C Tardiff · University Of Arizona · R01 · FY2025 · HL
Regulation of Neurogenesis by Stress and Antidepressants
$569,725Irwin Lucki · University Of Pennsylvania · U01 · FY2007 · MH
Spatiotemporal signaling and trafficking of the mu-opioid receptor
$569,713Ruth Huttenhain · Stanford University · R01 · FY2025 · DA
Methods and Strategies for Chemical Synthesis
$569,676Michael Kevin Brown · Trustees Of Indiana University · R35 · FY2025 · GM
Identifying and Targeting Mechanisms for Membrane Signaling in Human Cancer
$569,651Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2021 · CA
Safety and Effectiveness of Medications for Alcohol Use Disorder among HIV+/-
$569,604E. Jennifer Edelman · Yale University · P01 · FY2025 · AA
Late Transition Metal Catalysts for Organic Synthesis
$569,590Stephen L Buchwald · Massachusetts Institute Of Technology · R01 · FY2016 · GM
Profiling DataBase for Cocaine Medications
$569,570Novascreen Biosciences Corporation · R44 · FY2002 · DA
Metabolomics of subclinical and clinical cardiovascular disease
$569,468Dean P. Jones · Emory University · P20 · FY2016 · HL
Comparative functional genomics for lung cancer gene discovery
$569,332Eric Alejandro Sweet-Cordero · Stanford University · R01 · FY2010 · CA
Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis
$569,331Steven Mark Rowe · University Of Alabama At Birmingham · U01 · FY2023 · HL
Studies of Retinopathy of AIDS in the HAART Era
$569,322William R. Freeman · University Of California, San Diego · R01 · FY2008 · EY
Targeting the orphan nuclear receptor LRH-1 with small molecules
$569,274Eric A Ortlund · Emory University · R01 · FY2023 · DK